Lesha Emal, Laird David G, Nichols C Stewart, Miller L Erin, Orr Taylor, Roach Jordan T, Troy Christopher, Vaughn Brandy, Shimony Nir, Klimo Paul
Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN, USA.
Semmes Murphey Clinic, Memphis, TN, USA.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05021-0.
Readmission is a vital component of healthcare quality and is one of the core group metrics for quality-dependent outcomes. Currently, variables predictive of readmission following elective craniotomies for intracranial tumors in the pediatric population are not known. We sought to identify such variables in our population of children and young adults.
All elective craniotomies for tumor resection performed at our children's hospital from January 1, 2010, through December 31, 2022, were included for review, excluding those patients > 21 years of age. Demographic, clinical, and procedural covariates for each elective craniotomy for tumor resection were collected. Readmission was defined as readmission for any reason and to any service following discharge from the index admission (i.e., elective craniotomy). Readmission events were characterized as occurring within 90 days from discharge.
A total of 1,276 patients underwent a total of 1,497 elective craniotomies for tumor resection. The median age of the population at their index operations was 9.45 years, of which 58.5% of patients were male, 68.5% Caucasian, and 76.5% had private insurance. Most tumor resections were supratentorial (63.4%). There were 208 (13.9%) readmissions within 90 days of index operation, with 154 (74%) of those returning within the first 30 days. Bivariate analysis identified a number of associations, but multivariate testing found four significant predictors: age 0 to < 5 years (OR 1.55, p = 0.02), surgical time (OR 1.002, p = 0.02), high tumor grade (OR 3.15, p = 0.03), and return to the neurosurgical OR due to postoperative event (POE) (OR 2.81, p = 0.005).
Utilizing our large pediatric tumor database, we identified key drivers of readmission following elective tumor resection. These were young children (0 to < 5 years), surgical time, high tumor grade, and return to the neurosurgical OR due to POE, of which high tumor grade was the strongest. Future studies are warranted to explore the specific ways that these predictors increase readmission risk.
再入院是医疗质量的重要组成部分,也是质量相关结果的核心组指标之一。目前,对于儿科人群因颅内肿瘤进行择期开颅术后再入院的预测变量尚不清楚。我们试图在我们的儿童和青年人群中识别这些变量。
纳入2010年1月1日至2022年12月31日在我院儿童医院进行的所有择期肿瘤切除开颅手术病例进行回顾,排除年龄>21岁的患者。收集每例择期肿瘤切除开颅手术的人口统计学、临床和手术协变量。再入院定义为自首次入院(即择期开颅手术)出院后因任何原因再次入院至任何科室。再入院事件定义为出院后90天内发生。
共有1276例患者接受了1497次择期肿瘤切除开颅手术。患者首次手术时的中位年龄为9.45岁,其中58.5%为男性,68.5%为白种人,76.5%有私人保险。大多数肿瘤切除术位于幕上(63.4%)。首次手术后90天内有208例(13.9%)再入院,其中154例(74%)在术后30天内再次入院。二元分析确定了一些关联,但多变量检验发现了四个显著预测因素:年龄0至<5岁(OR 1.55,p = 0.02)、手术时间(OR 1.002,p = 0.02)、高肿瘤分级(OR 3.15,p = 0.03)以及因术后事件(POE)返回神经外科手术室(OR 2.81,p = 0.005)。
利用我们庞大的儿科肿瘤数据库,我们确定了择期肿瘤切除术后再入院的关键驱动因素。这些因素包括幼儿(0至<5岁)、手术时间、高肿瘤分级以及因POE返回神经外科手术室,其中高肿瘤分级是最强的因素。未来有必要开展研究以探索这些预测因素增加再入院风险的具体方式。